284 related articles for article (PubMed ID: 33515927)
21. Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.
Gao F; Chen J; Wei D; Wu B; Zhou M
Front Med; 2018 Apr; 12(2):224-228. PubMed ID: 28752350
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Mohseni R; Mahdavi Sharif P; Behfar M; Modaresi MR; Shirzadi R; Mardani M; Jafari L; Jafari F; Nikfetrat Z; Hamidieh AA
Stem Cell Res Ther; 2023 Sep; 14(1):256. PubMed ID: 37726865
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Gazourian L; Rogers AJ; Ibanga R; Weinhouse GL; Pinto-Plata V; Ritz J; Soiffer RJ; Antin JH; Washko GR; Baron RM; Ho VT
Am J Hematol; 2014 Apr; 89(4):404-9. PubMed ID: 24375545
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
[TBL] [Abstract][Full Text] [Related]
25. Quantitative computed tomography assessment of graft-versus-host disease-related bronchiolitis obliterans in children: A pilot feasibility study.
Kim HG; Shin HJ; Kim YH; Sohn MH; Lyu CJ; Kim MJ; Kim KW; Lee MJ
Eur Radiol; 2015 Oct; 25(10):2931-6. PubMed ID: 25809743
[TBL] [Abstract][Full Text] [Related]
26. Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation.
Yomota M; Yanagawa N; Sakai F; Yamada Y; Sekiya N; Ohashi K; Okamura T
Medicine (Baltimore); 2019 Jan; 98(1):e13951. PubMed ID: 30608429
[TBL] [Abstract][Full Text] [Related]
27. Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Galbán CJ; Boes JL; Bule M; Kitko CL; Couriel DR; Johnson TD; Lama V; Telenga ED; van den Berge M; Rehemtulla A; Kazerooni EA; Ponkowski MJ; Ross BD; Yanik GA
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1592-8. PubMed ID: 24954547
[TBL] [Abstract][Full Text] [Related]
28. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
[TBL] [Abstract][Full Text] [Related]
29. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans.
Mosquera RA; Hashmi SS; Pacheco SE; Reverdin A; Chevallier J; Colasurdo GN
Clin Respir J; 2014 Jan; 8(1):63-71. PubMed ID: 23800208
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of Lower Respiratory Tract Infections and Community-Acquired Respiratory Viruses in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
Epstein DJ; Liang EC; Sharifi H; Lai YK; Arai S; Graber-Naidich A; Sundaram V; Nelson J; Hsu JL
Transplant Cell Ther; 2022 Oct; 28(10):705.e1-705.e10. PubMed ID: 35872303
[TBL] [Abstract][Full Text] [Related]
31. Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus.
Yang CF; Wu MT; Chiang AA; Lai RS; Chen C; Tiao WM; McLoud TC; Wang JS; Pan HB
AJR Am J Roentgenol; 1997 Apr; 168(4):1045-50. PubMed ID: 9124113
[TBL] [Abstract][Full Text] [Related]
32. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
33. Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation.
Bondeelle L; Chevret S; Hurabielle C; Samy L; Goletto T; Costantini A; Sicre de Fontbrune F; Michonneau D; Socié G; Tazi A; Bouaziz JD; Bergeron A
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2115-2120. PubMed ID: 32738501
[TBL] [Abstract][Full Text] [Related]
34. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.
Bergeron A; Godet C; Chevret S; Lorillon G; Peffault de Latour R; de Revel T; Robin M; Ribaud P; Socié G; Tazi A
Bone Marrow Transplant; 2013 Jun; 48(6):819-24. PubMed ID: 23208317
[TBL] [Abstract][Full Text] [Related]
35. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
[TBL] [Abstract][Full Text] [Related]
36. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
Kordjazy N; Amini S
Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of inhaled tiotropium add-on to budesonide/formoterol in patients with bronchiolitis obliterans developing after hematopoietic stem cell transplantation.
Lim JU; Park S; Yoon JH; Lee SE; Cho BS; Kim YJ; Lee S; Kim HJ; Rhee CK
Respir Med; 2023 Nov; 218():107410. PubMed ID: 37696312
[TBL] [Abstract][Full Text] [Related]
38. [A retrospective study of 10 cases of post-transplant bronchiolitis obliterans].
Chai JJ; Liu T; Cai BQ; Zhu HD
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jul; 40(7):504-508. PubMed ID: 28728274
[No Abstract] [Full Text] [Related]
39. Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance?
Konen E; Gutierrez C; Chaparro C; Murray CP; Chung T; Crossin J; Hutcheon MA; Paul NS; Weisbrod GL
Radiology; 2004 May; 231(2):467-73. PubMed ID: 15128992
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
